These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12848627)

  • 1. Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
    Creed TJ; Norman MR; Probert CS; Harvey RF; Shaw IS; Smithson J; Anderson J; Moorghen M; Gupta J; Shepherd NA; Dayan CM; Hearing SD
    Aliment Pharmacol Ther; 2003 Jul; 18(1):65-75. PubMed ID: 12848627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
    Creed TJ; Probert CS; Norman MN; Moorghen M; Shepherd NA; Hearing SD; Dayan CM;
    Aliment Pharmacol Ther; 2006 May; 23(10):1435-42. PubMed ID: 16669958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
    Sands BE; Sandborn WJ; Creed TJ; Dayan CM; Dhanda AD; Van Assche GA; Greguš M; Sood A; Choudhuri G; Stempien MJ; Levitt D; Probert CS
    Gastroenterology; 2012 Aug; 143(2):356-64.e1. PubMed ID: 22549092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
    Paoluzi OA; Pica R; Marcheggiano A; Crispino P; Iacopini F; Iannoni C; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1751-9. PubMed ID: 12269968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
    Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.
    Probert CS; Hearing SD; Schreiber S; Kühbacher T; Ghosh S; Arnott ID; Forbes A
    Gut; 2003 Jul; 52(7):998-1002. PubMed ID: 12801957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.
    Domènech E; Garcia-Planella E; Bernal I; Rosinach M; Cabré E; Fluvià L; Boix J; Gassull MA
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2061-5. PubMed ID: 12452938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.
    Fernández-Bañares F; Bertrán X; Esteve-Comas M; Cabré E; Menacho M; Humbert P; Planas R; Gassull MA
    Am J Gastroenterol; 1996 Dec; 91(12):2498-9. PubMed ID: 8946973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis.
    Ardizzone S; Molteni P; Imbesi V; Bollani S; Bianchi Porro G
    J Clin Gastroenterol; 1997 Jul; 25(1):330-3. PubMed ID: 9412914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
    Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
    Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
    Fiorino G; Gilardi D; Naccarato P; Sociale OR; Danese S
    Dig Liver Dis; 2014 Apr; 46(4):330-4. PubMed ID: 24462118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
    Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B
    J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.